A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
NCT01539395 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-09-02
Summary
This is a Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis.
Conditions
Interventions
- OTHER
-
MSDx Complex-1 Biomarker Test
A biomarker test for the level of MSDx Complex-1
Sponsors & Collaborators
-
MSDx, Inc.
lead INDUSTRY
Principal Investigators
-
Jeanette K Wendt, MD · Northwest NeuroSpecialists, PLLC
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-04-30
- Completion
- 2012-07-31
Countries
- United States
Study Locations
More Related Trials
-
Venous Irregularities, Flow and Perfusion in MS Study
NCT01593904 ·Status: UNKNOWN
-
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
NCT04892134 ·Status: RECRUITING
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
NCT02845635 ·Status: COMPLETED
-
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
NCT01723709 ·Status: COMPLETED
-
MS-ResearchBiomarkerS
NCT05204459 ·Status: RECRUITING
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
The MS-LINK™ Outcomes Study
NCT04735406 ·Status: COMPLETED
-
Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
NCT02326935 ·Status: TERMINATED ·Phase: PHASE1
-
Scan-Rescan Sub-Study of MS PATHS
NCT04123353 ·Status: COMPLETED
-
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
NCT01632293 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Measurement of Relaxin Peptide in Multiple Sclerosis (MS)
NCT01909492 ·Status: COMPLETED
-
Biomarkers in Multiple Sclerosis
NCT00325988 ·Status: COMPLETED
-
ATX-MS-1467 in Multiple Sclerosis
NCT01973491 ·Status: COMPLETED ·Phase: PHASE2
-
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT04873492 ·Status: RECRUITING ·Phase: NA
-
Immunologic Biomarker Profile of Cerebrospinal Fluid
NCT04202055 ·Status: COMPLETED
-
Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients
NCT01601119 ·Status: COMPLETED
-
T Cell Profiling in Patients with Multiple Sclerosis
NCT04789551 ·Status: NOT_YET_RECRUITING
-
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
NCT02784210 ·Status: RECRUITING ·Phase: PHASE2
-
Risk Factors in Early Multiple Sclerosis
NCT03586986 ·Status: UNKNOWN
-
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
NCT01895335 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study
NCT05197699 ·Status: TERMINATED